Addex Therapeutics Ltd Interest Expense
Addex Therapeutics Ltd (ADXN) reported Interest Expense of CHF 334 for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2025-09-30
- Addex Therapeutics Ltd interest expense for the quarter ending 2025-06-30 was 334.00 CHF, a 23.57% decline year-over-year.
- Addex Therapeutics Ltd interest expense for the quarter ending 2024-06-30 was 437.00 CHF, a 369.89% increase year-over-year.
- Addex Therapeutics Ltd interest expense for the quarter ending 2023-06-30 was 93.00 CHF, a 98.77% decline year-over-year.
- Addex Therapeutics Ltd interest expense for the quarter ending 2022-06-30 was 7.57K CHF, a 56.15% decline year-over-year.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | 334.00 CHF 6-K · filed 2025-09-30 | 365.00 CHF 6-K · filed 2025-09-30 | ||
| 2024-12-31 | 1.61K CHF 20-F · filed 2025-05-15 | |||
| 2024-06-30 | 437.00 CHF 6-K · filed 2025-09-30 | 583.00 CHF 6-K · filed 2025-09-30 | ||
| 2023-12-31 | 1.64K CHF 20-F · filed 2025-05-15 | |||
| 2023-06-30 | 93.00 CHF 6-K/A · filed 2023-12-21 | 93.00 CHF 6-K/A · filed 2023-12-21 | ||
| 2022-12-31 | 2.07K CHF 20-F · filed 2025-05-15 | 25.88K CHF 20-F · filed 2023-03-30 | ||
| 2022-06-30 | 7.57K CHF 6-K/A · filed 2023-12-21 | 24.37K CHF 6-K/A · filed 2023-12-21 | ||
| 2021-12-31 | 39.15K CHF 20-F · filed 2024-04-18 | |||
| 2021-06-30 | 17.27K CHF 6-K/A · filed 2022-09-14 | 31.40K CHF 6-K/A · filed 2022-09-14 | ||
| 2020-12-31 | 50.46K CHF 20-F · filed 2023-03-30 | |||
| 2019-12-31 | 105.92K CHF 20-F · filed 2022-03-10 | |||
| 2018-12-31 | 134.31K CHF 20-F · filed 2021-03-11 | |||
| 2017-12-31 | 171.00 CHF 20-F · filed 2020-04-27 |